Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Stockomendation Crowdfunding on Seedrs NOW!
- Avoid Hastings Group Holdings (HSTG) by Robert Faulkner in The Motley Fool
- Avoid Direct Line Insurance Group (DLG) by Robert Faulkner in The Motley Fool
- Buy Wishbone Gold (WSBN) by Tom Winnifrith in Hot Stock Rockets
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy Alba Mineral Resources (ALBA) by Tom Winnifrith in Hot Stock Rockets
- Buy Bellway (BWY) by Berenberg
- Buy Bellway (BWY) by Canaccord Genuity
- Stockomendation Crowdfunding on Seedrs NOW!
- Hold South32 Limited (DI) (S32) by HSBC
- Hold Rank Group (RNK) by Canaccord Genuity
- Buy Shanta Gold Ltd. (SHG) by Numis
- Stockomendation Crowdfunding on Seedrs NOW!
- Hold Inchcape (INCH) by Berenberg
- Buy Provident Financial (PFG) by Numis
- Hold Pendragon (PDG) by Berenberg
- Stockomendation Crowdfunding on Seedrs NOW!
- Hold Crest Nicholson Holdings (CRST) by Berenberg
- Avoid Zytronic (ZYT) by Steve Moore in ShareProphets
- Hold easyJet (EZJ) by Societe Generale
- Stockomendation Crowdfunding on Seedrs NOW!
- Buy Wizz Air Holdings (WIZZ) by Societe Generale
- Hold Safestyle UK (SFE) by Liberum Capital
- Buy WPP (WPP) by UBS
- Stockomendation Crowdfunding on Seedrs NOW!
- Sell Relx plc (REL) by UBS
- Hold International Consolidated Airlines Group SA (CDI) (IAG) by Societe Generale
GlaxoSmithKline (GSK)
Pharma and Biotech Sector
-
Latest quote
1,557.60p (mid)
-
Current Change (%)
3.10%
-
Price
Bid: 1,557.20p
Offer: 1,557.40p
-
Today
High: 1,558.40p
Low: 1,516.00p
-
This year
High: 1,619.40p
Low: 1,242.80p
-
Information
Volume: 6,713,008
Market Cap: £77247.04M
GlaxoSmithKline Overview
UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
GlaxoSmithKline RNS Feed
| Title | Release date |
|---|---|
| ViiV submits HIV 2DR regulatory application to FDA | 16:00 - October 18, 2018 |
| Director/PDMR Shareholding | 09:34 - October 18, 2018 |
| Director/PDMR Shareholding | 17:56 - October 17, 2018 |
| Director/PDMR Shareholding | 17:50 - October 17, 2018 |
| Director/PDMR Shareholding | 11:30 - October 17, 2018 |
| Director/PDMR Shareholding | 16:53 - October 16, 2018 |
| Director/PDMR Shareholding | 09:30 - October 16, 2018 |
| Director/PDMR Shareholding | 09:30 - October 16, 2018 |
| Director/PDMR Shareholding | 15:30 - October 10, 2018 |
| Total Voting Rights | 13:58 - October 1, 2018 |
| Director/PDMR Shareholding | 16:35 - September 27, 2018 |
| CHMP recommends expansion of Trelegy COPD label | 12:30 - September 21, 2018 |
| ViiV submits HIV 2DR regulatory application to EMA | 09:00 - September 14, 2018 |
| Director/PDMR Shareholding | 17:43 - September 12, 2018 |
| New analysis on efficacy of anti-IL5 biologics SEA | 08:00 - September 10, 2018 |
NOTE: This is based on 200 open tips for this company
